Begin main content

The CADTH Scientific Advice Program is a voluntary, non-binding, and confidential fee-for-service consultation. Through this Program, pharmaceutical companies are provided with advice on their early drug development plans from a Canadian health technology assessment perspective.

Latest News

New Opportunity: Parallel Scientific Advice From CADTH and NICE

CADTH is pleased to announce a new collaboration with England’s NICE (National Institute for Health and Care Excellence) to offer parallel scientific advice to pharmaceutical companies. Applications are now being accepted. To learn more about this opportunity, please contact CADTH Scientific Advice at

Published : February 6, 2019